切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2024, Vol. 18 ›› Issue (03) : 129 -147. doi: 10.3877/cma.j.issn.1674-3903.2024.03.001

所属专题: 指南共识

标准与指南

中国胰肾联合移植临床诊疗指南
中华医学会器官移植学分会, 中国医疗保健国际交流促进会肾脏移植学分会   
  1. 1. 广州医科大学附属第二医院,510260 广州
    2. 西安交通大学第一附属医院,710061 西安
  • 收稿日期:2024-04-23 出版日期:2024-06-25
  • 基金资助:
    广州地区临床高新和重大技术项目(2023GX041)

Clinical guideline for diagnosis and treatment of combined pancreas and kidney transplantation in China

Branch of Organ Transplantation of Chinese Medical Association, Branch of Kidney Transplantation, China International Exchange and Promotive Association for Medical and Health Care   

  1. 1. the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260
    2. the First Affiliated Hospital of Xi′an Jiaotong University, Xi′an 710061
  • Received:2024-04-23 Published:2024-06-25
引用本文:

中华医学会器官移植学分会, 中国医疗保健国际交流促进会肾脏移植学分会. 中国胰肾联合移植临床诊疗指南[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 129-147.

Branch of Organ Transplantation of Chinese Medical Association, Branch of Kidney Transplantation, China International Exchange and Promotive Association for Medical and Health Care. Clinical guideline for diagnosis and treatment of combined pancreas and kidney transplantation in China[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(03): 129-147.

糖尿病是全球性疾病,而中国成人糖尿病患者数量位居世界第一。胰肾联合移植作为治疗终末期糖尿病肾病或糖尿病合并终末期肾病最有效的手段,在1型糖尿病和部分2型糖尿病患者中可获得同样的疗效。为了进一步实现胰肾联合移植临床诊治标准化,由中华医学会器官移植学分会组织器官移植学专家,制订《中国胰肾联合移植临床诊疗指南》,指南采用2009版牛津大学循证医学中心的证据分级与推荐强度标准制订,针对胰肾联合移植类型、适应证和禁忌证、供器官及受者评估、器官获取及修整、术式选择、并发症的诊治、受者随访等方面的32个关键临床问题,给出了较为详细的循证推荐,旨在通过循证指导临床实践,全面提升我国胰肾联合移植诊治水平。

Diabetes mellitus is a global disease, and China ranks first in the world in terms of the number of adults with diabetes mellitus. Combined pancreas and kidney transplantation, as the most effective treatment for end-stage diabetic nephropathy or diabetes mellitus combined with end-stage renal disease, can achieve the same therapeutic effect in patients with type 1 diabetes mellitus and some patients with type 2 diabetes mellitus. In order to further standardize the clinical diagnosis and treatment of combined pancreas and kidney transplantation, organ transplantation experts from the Branch of Organ Transplantation of Chinese Medical Association formulated the clinical guideline for diagnosis and treatment of combined pancreas and kidney transplantation in China, which is formulated by adopting the 2009 version of the Oxford Centre for Evidence-Based Medicine′s criteria for grading the evidence and the strength of the recommendation. The guideline provides detailed evidence-based recommendations on 32 key clinical issues, including type of combined pancreas and kidney transplantation, indications and contraindications, donor organ and recipient evaluation, organ procurement and repair, selection of surgical procedures, diagnosis and treatment of complications, and recipient follow-up, aiming at guiding the clinical practice through evidence-based guidance to comprehensively improve the diagnosis and treatment of combined pancreas and kidney transplantation in China.

表1 牛津大学循证医学中心证据分级与推荐强度分级标准
1
Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet][M]. 10th ed. Brussels: International Diabetes Federation, 2021.
2
Ruiz-Ortega M, Rodrigues-Diez RR, Lavoz C, et al. Special issue " diabetic nephropathy: diagnosis, prevention and treatment" [J]. J Clin Med, 2020, 9(3): 813.
3
Montagud-Marrahi E, Cuadrado-Payán E, Hermida E, et al. Preemptive simultaneous pancreas kidney transplantation has survival benefit to patients[J]. Kidney Int, 2022, 102(2): 421-430.
4
Boggi U, Vistoli F, Andres A, et al. First World Consensus Conference on pancreas transplantation: Part II - recommendations[J]. Am J Transplant, 2021, 21(Suppl 3): S17-S59.
5
中华医学会器官移植学分会. 胰肾联合移植临床技术规范(2020版)[J]. 器官移植2020, 11(3): 332-343.
6
中华医学会器官移植学分会,中国医师协会器官移植医师分会. 中国胰腺移植诊疗指南(2016版)[J]. 中华器官移植杂志2016, 37(10): 627-634.
7
Dholakia S, Oskrochi Y, Easton G, et al. Advances in pancreas transplantation[J]. J R Soc Med, 2016, 109(4): 141-146.
8
Dean PG, Kukla A, Stegall MD, et al. Pancreas transplantation[J]. BMJ, 2017, 357: j1321.
9
Samoylova ML, Borle D, Ravindra KV. Pancreas transplantation: indications, techniques, and outcomes[J]. Surg Clin North Am, 2019, 99(1): 87-101.
10
Kobayashi T, Gruessner AC, Wakai T, et al. Three types of simultaneous pancreas and kidney transplantation[J]. Transplant Proc, 2014, 46(3): 948-953.
11
于立新,姚冰,邓文锋,等. 改良式胰液肠腔引流胰十二指肠及肾一期联合移植(附二例报告)[J]. 中华泌尿外科杂志2003, 24(11): 17-20.
12
Meirelles Júnior RF, Salvalaggio P, Pacheco-Silva A. Pancreas transplantation: review[J]. Einstein (Sao Paulo), 2015, 13(2): 305-309.
13
Hau HM, Jahn N, Brunotte M, et al. Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft[J]. BMC Endocr Disord, 2020, 20(1): 30.
14
Weems P, Cooper M. Pancreas transplantation in type Ⅱ diabetes mellitus[J]. World J Transplant, 2014, 4(4): 216-221.
15
Braun MM, Khayat M. Kidney disease: end-stage renal disease[J]. FP Essent, 2021509:26-32.
16
Lombardo C, Perrone VG, Amorese G, et al. Update on pancreatic transplantation on the management of diabetes[J]. Minerva Med, 2017, 108(5): 405-418.
17
Plotkin JS, Scott VL, Pinna A, et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation[J]. Liver Transpl Surg, 1996, 2(6): 426-430.
18
Vallet-Pichard A, Fontaine H, Mallet V, et al. Viral hepatitis in solid organ transplantation other than liver[J]. J Hepatol, 2011, 55(2): 474-478.
19
Ladin K, Daniels A, Osani M, et al. Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis[J]. Transplant Rev (Orlando), 2018, 32(1): 16-28.
20
Hau HM, Jahn N, Brunotte M, et al. Pre-operative ankle-brachial index for cardiovascular risk assessment in simultaneous pancreas-kidney transplant recipients: a simple and elegant strategy! [J]. BMC Surg, 2021, 21(1): 156.
21
Babu BI, Shapiro AMJ. Current evidence in the management of premalignant cystic lesions of the pancreas in patients undergoing liver transplantation[J]. Pancreas, 2022, 51(2): 117-120.
22
Mattiazzi AD, Centeno A, Amador A, et al. Highly sensitized patients: Miami Transplant Institute experience[J]. Clin Transpl, 2014: 171-178.
23
Ciancio G, Burke GW. Type 2 diabetes: is pancreas transplantation an option?[J]. Curr Diab Rep, 2014, 14(11): 542.
24
Kerr HR, Hatipoglu B, Krishnamurthi V. Pancreas transplant for diabetes mellitus[J]. Cleve Clin J Med, 2015, 82(11): 738-744.
25
de Kort H, Roufosse C, Bajema IM, et al. Pancreas transplantation, antibodies and rejection: where do we stand?[J]. Curr Opin Organ Transplant, 2013, 18(3): 337-344.
26
Chen J, Mikhail DM, Sharma H, et al. Donor age is the most important predictor of long term graft function in donation after cardiac death simultaneous pancreas-kidney transplantation: a retrospective study[J]. Am J Surg, 2019, 218(5): 978-987.
27
Gruessner AC, Laftavi MR, Pankewycz O, et al. Simultaneous pancreas and kidney transplantation-is it a treatment option for patients with type 2 diabetes mellitus?An analysis of the international pancreas transplant registry[J]. Curr Diab Rep, 2017, 17(6): 44.
28
Krieger NR, Odorico JS, Heisey DM, et al. Underutilization of pancreas donors[J]. Transplantation, 2003, 75(8): 1271-1276.
29
Schenker P, Wunsch A, Ertas N, et al. Long-term results after simultaneous pancreas-kidney transplantation using donors aged 45 years or older[J]. Transplant Proc, 2008, 40(4): 923-926.
30
Van der Werf WJ, Odorico J, D′Alessandro AM, et al. Utilization of pediatric donors for pancreas transplantation[J]. Transplant Proc, 1999, 31 (1-2): 610-611.
31
石炳毅,薛武军. 中国器官移植临床诊疗技术规范(2020版)[M]. 北京:人民卫生出版社,2017.
32
White SA, Shaw JA, Sutherland DE. Pancreas transplantation[J]. Lancet, 2009, 373(9677): 1808-1817.
33
Lonze BE, Baptiste G, Ali NM, et al. Pancreas transplantation from hepatitis C viremic donors to uninfected recipients[J]. Am J Transplant, 2021, 21(5): 1931-1936.
34
Van Pilsum Rasmussen SE, Bowring MG, Shaffer AA, et al. Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers[J]. Clin Transplant, 2018, 32(10): e13365.
35
Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future[J]. Clin Transplant, 2010, 24(4): 433-449.
36
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7): 412-419.
37
Törn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of beta cell function in autoimmune diabetes[J]. J Clin Endocrinol Metab, 2000, 85(12): 4619-4623.
38
李霞,周智广,亓海英,等. 用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J]. 中南大学学报(医学版), 2004, 29(4): 419-423.
39
Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients[J]. Biomark Insights, 2016, 11: 95-104.
40
Muñoz-Bellvís L, López-Sánchez J. Donor risk factors in pancreas transplantation[J]. World J Transplant, 2020, 10(12): 372-380.
41
Axelrod DA, Sung RS, Meyer KH, et al. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization[J]. Am J Transplant, 201010(4): 837-845.
42
Hesse UJ, Sutherland DE. Influence of serum amylase and plasma glucose levels in pancreas cadaver donors on graft function in recipients[J]. Diabetes1989, 38(Suppl 1): S1-S3.
43
Vinkers MT, Rahmel AO, Slot MC, et al. How to recognize a suitable pancreas donor: a Eurotransplant study of preprocurement factors[J]. Transplant Proc, 2008, 40(5): 1275-1278.
44
Bertolotto M, D′Onofrio M, Martone E, et al. Ultrasonography of the pancreas. 3. Doppler imaging[J]. Abdom Imaging, 2007, 32(2): 161-170.
45
Clevert DA, D′Anastasi M, Jung EM.. Contrast-enhanced ultrasound and microcirculation: efficiency through dynamics-current developments[J]. Clin Hemorheol Microcirc, 2013, 53(1-2): 171-186.
46
D′Alessandro C, Todisco M, Di Bella C, et al. Surgical complications after pancreatic transplantation: A computed tomography imaging pictorial review[J]. World J Gastroenterol, 2023, 29(46): 6049-6059.
47
Hagspiel KD, Nandalur K, Burkholder B, et al. Contrast-enhanced MR angiography after pancreas transplantation: normal appearance and vascular complications[J]. AJR Am J Roentgenol, 2005, 184(2): 465-473.
48
晋云,陈刚,张绍祥,等. 胰腺及其周围结构的三维重建研究[J]. 中华消化外科杂志20087(5): 369-371.
49
Rudolph EN, Dunn TB, Sutherland DER, et al. Optimizing outcomes in pancreas transplantation: Impact of organ preservation time[J]. Clin Transplant, 2017, 31(9): e13035.
50
Humar A, Kandaswamy R, Drangstveit MB, et al. Prolonged preservation increases surgical complications after pancreas transplants[J]. Surgery, 2000, 127(5): 545-551.
51
李林德,陆兵,吴基华,等. 英国胰腺移植实践指南解读[J/CD]. 实用器官移植电子杂志2023, 11(6): 495-501.
52
Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization[J]. N Engl J Med, 2004, 351(13): 1296-1305.
53
Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association[J]. Circulation, 1999, 100(10): 1132-1133.
54
Yiannoullou P, Summers A, Goh SC, et al. Major adverse cardiovascular events following simultaneous pancreas and kidney transplantation in the United Kingdom[J]. Diabetes Care, 2019, 42(4): 665-673.
55
Sucher R, Rademacher S, Jahn N, et al. Effects of simultaneous pancreas-kidney transplantation and kidney transplantation alone on the outcome of peripheral vascular diseases[J]. BMC Nephrol, 2019, 20(1): 453.
56
Mangus RS, Powelson J, Kinsella SB, et al. Pretransplant coronary artery disease associated with worse clinical outcomes in pancreas transplantation[J]. Clin Transplant, 2013, 27(4): E442-E447.
57
Rijkse E, van Dam JL, Roodnat JI, et al. The prognosis of kidney transplant recipients with aorto-iliac calcification: a systematic review and meta-analysis[J]. Transpl Int, 2020, 33(5): 483-496.
58
Lewis JR, Wong G, Taverniti A, et al. Association between aortic calcification, cardiovascular events, and mortality in kidney and pancreas-kidney transplant recipients[J]. Am J Nephrol, 2019, 50(3): 177-186.
59
Cohen DJ, Ratner LE. Type 2 diabetes: the best transplant option is still uncertain[J]. Clin J Am Soc Nephrol, 2012, 7(4): 530-532.
60
Bazerbachi F, Selzner M, Marquez MA, et al. Portal venous versus systemic venous drainage of pancreas grafts: impact on long-term results[J]. Am J Transplant, 2012, 12(1): 226-232.
61
Riad SM, Keys DO, Jackson S, et al. Enteric conversion of bladder drained pancreas as a predictor of outcomes in almost 600 recipients at a single center[J]. Transplant Direct, 2020, 6(5): e550.
62
Lam VW, Pleass HC, Hawthorne W, et al. Evolution of pancreas transplant surgery[J]. ANZ J Surg, 2010, 80(6): 411-418.
63
Fridell JA, Powelson JA, Sanders CE, et al. Preparation of the pancreas allograft for transplantation[J]. Clin Transplant, 2011, 25 (2): E103-E112.
64
Witte B, Fröber R, Linss W. Unusual blood supply to the pancreas by a dorsal pancreatic artery[J]. Surg Radiol Anat, 2001, 23(3): 197-200.
65
Nghiem DD. Revascularization of the gastroepiploic artery in pancreas transplant[J]. Transpl Int, 2008, 21(8): 774-777.
66
罗鲜樟,王心强,陈艳,等. 胰肾联合移植中胃十二指肠动脉的重建[J]. 中华器官移植杂志2014, 35(8): 496-500.
67
付迎欣,王辉,冯钢,等. 胰肾联合移植145例单中心回顾分析[J].中华器官移植杂志2019, 40(5): 260-265.
68
Friedrich J, Charpentier K, Marsh CL, et al. Outcomes with the selective use of enteric exocrine drainage in pancreas transplantation[J]. Transplant Proc, 2004, 36(10): 3101-3104.
69
Ciancio G, Sageshima J, Chen L, et al. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years[J]. Am J Transplant, 2012, 12(12): 3363-3376.
70
Frystyk J, Ritzel RA, Maubach J, et al. Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-Ⅰ axis[J]. J Clin Endocrinol Metab, 2008, 93(5): 1758-1766.
71
Alonso A, Fernández C, Cillero S, et al. Effects of portal versus systemic venous drainage in pancreas and kidney-pancreas transplantation[J]. Transplant Proc, 2007, 39(7): 2335-2337.
72
Ollinger R, Margreiter C, Bösmüller C, et al. Evolution of pancreas transplantation: long-term results and perspectives from a high volume center[J]. Ann Surg, 2012, 256(5): 780-786.
73
Kandaswamy R, Stock PG, Miller J, et al. OPTN/SRTR 2020 annual sata report: pancreas[J]. Am J Transplant, 2022, 22(Suppl 2): S137-S203.
74
Farney AC, Doares W, Rogers J, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation[J]. Transplantation, 2009, 88(6): 810-819.
75
Aziz F, Parajuli S, Kaufman D, et al. Induction in pancreas transplantation: T-cell depletion versus IL-2 receptor blockade[J]. Transplant Direct, 2022, 8(12): e1402.
76
Bazerbachi F, Selzner M, Boehnert MU, et al. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome[J]. Transplantation, 2011, 92(9):1039-1043.
77
Kaufman DB, Burke GW III, Bruce DS, et al. Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation[J]. Am J Transplant, 2003, 3(7): 855-864.
78
Gruessner AC. 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR) [J]. Rev Diabet Stud, 2011, 8(1): 6-16.
79
Malaise J, Saudek F, Boucek P, et al. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results[J]. Transplant Proc, 2005, 37(6): 2843-2845.
80
Falconer SJ, Jansen C, Oniscu GC. Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients[J]. Transplant Proc, 2014, 46(5): 1458-1462.
81
Merion RM, Henry ML, Melzer JS, et al. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation[J]. Transplantation, 2000, 70(1): 105-111.
82
Cantarovich D, Karam G, Hourmant M, et al. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation[J]. Am J Transplant, 2005, 5(6): 1332-1338.
83
Gruessner AC, Gruessner RW. P.135: Better long-term patient and kidney graft outcome for simultaneous pancreas/kidney (SPK) versus kidney transplant alone (KTA) recipients[J]. Transplantation, 2021, 105(12 Supp 1): S53.
84
Redfield RR, Kaufman DB, Odorico JS. Diagnosis and treatment of pancreas rejection[J]. Curr Transplant Rep, 2015, 2(2): 169-175.
85
中华医学会器官移植学分会.中国器官移植超声影像学诊疗技术规范(2019版)[J].器官移植2019, 10(1): 16-31.
86
中华医学会器官移植学分会. 移植胰腺病理学临床操作规范(2019版)[J]. 器官移植201910(6):628-637.
87
Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema[J]. Am J Transplant, 2011, 11(9): 1792-1802.
88
Uva PD, Odorico JS, Giunippero A, et al. Laparoscopic biopsies in pancreas transplantation[J]. Am J Transplant, 2017, 17(8): 2173-2177.
89
Parajuli S, Arpali E, Astor BC, et al. Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection -a retrospective Study[J]. Transpl Int, 2018, 31(1): 32-37.
90
Horneland R, Paulsen V, Lindahl JP, et al. Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges-but offers improved endoscopic access for scheduled biopsies and therapeutic interventions[J]. Am J Transplant, 2015, 15(1): 242-250.
91
Klassen DK, Weir MR, Cangro CB, et al. Pancreas allograft biopsy: safety of percutaneous biopsy-results of a large experience[J]. Transplantation, 2002, 73(4): 553-555.
92
Drachenberg CB, Odorico J, Demetris AJ, et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel[J]. Am J Transplant, 2008, 8(6): 1237-1249.
93
Loupy A, Haas M, Roufosse C, et al. The banff 2019 kidney meeting report (i): updates on and clarification of criteria for t cell- and antibody-mediated rejection[J]. Am J Transplant, 2020, 20(9): 2318-2331.
94
Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system[J]. Transplantation, 1997, 63(11):1579-1586.
95
Drachenberg CB, Buettner-Herold M, Aguiar PV, et al. Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods[J]. Am J Transplant, 2024, 24(3): 362-379.
96
Uva PD, Papadimitriou JC, Drachenberg CB, et al. Graft dysfunction in simultaneous pancreas kidney transplantation (SPK): results of concurrent kidney and pancreas allograft biopsies[J]. Am J Transplant, 2019, 19(2): 466-474.
97
Dong M, Parsaik AK, Kremers W, et al. Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation[J]. Am J Transplant, 2013, 13(4): 1019-1025.
98
Moinuddin I, Yaqub MS, Taber T, et al. Isolated pancreas rejections do not have an adverse impact on kidney graft survival whereas kidney rejections are associated with adverse pancreas graft survival in simultaneous pancreas kidney transplantation[J]. J Nephrol, 2018, 31(2): 307-315.
99
Aziz F, Parajuli S, Uddin S, et al. How should pancreas transplant rejection be treated?[J]. Transplantation, 2019, 103(9): 1928-1934.
100
de Kort H, Munivenkatappa RB, Berger SP, et al. Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients[J]. Am J Transplant, 2010, 10(7): 1660-1667.
101
Rangel EB, Malheiros DM, de Castro MC, et al. Antibody mediated rejection (AMR) after pancreas and pancreas-kidney transplantation[J]. Transpl Int, 2010, 23(6): 602-610.
102
Niederhaus SV, Leverson GE, Lorentzen DF, et al. Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes[J]. Am J Transplant, 2013, 13(11): 2945-2955.
103
中华医学会器官移植学分会. 胰腺移植临床技术操作规范[J]. 中华器官移植杂志2019, 40(11): 643-659.
104
Farney AC, Rogers J, Stratta RJ. Pancreas graft thrombosis: Causes, prevention, diagnosis, and intervention[J]. Curr Opin Organ Transplant, 2012, 17(1): 87-92.
105
郑建明,曹玉,宋文利. 第一届胰腺移植国际共识大会胰腺移植临床实践指南解读[J]. 中华器官移植杂志2022, 43(10): 577-584.
106
刘路浩,方佳丽,李光辉,等. 胰肾联合移植术后抗凝治疗方案的回顾性队列研究[J]. 中华器官移植杂志2021, 42(11): 663-668.
107
Khubutia MS, Pinchuk AV, Dmitriev IV, et al. Surgical complications after simultaneous pancreas-kidney transplantation: a single-center experience[J]. Asian J Surg, 2016, 39(4): 232-237.
108
Humar A, Ramcharan T, Kandaswamy R, et al. Technical failures after pancreas transplants: why grafts fail and the risk factors-a multivariate analysis[J]. Transplantation, 2004, 78(8): 1188-1192.
109
Sollinger HW, Odorico JS, Becker YT, et al. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up[J]. Ann Surg, 2009, 250(4): 618-630.
110
Troppmann C. Complications after pancreas transplantation[J]. Curr Opin Organ Transplant, 2010, 15(1): 112-118.
111
Boggi U, Vistoli F, Del Chiaro M, et al. Total duodenectomy with enteric duct drainage: a rescue operation for duodenal complications occurring after pancreas transplantation[J]. Am J Transplant, 2010, 10(3): 692-697.
112
Pieroni E, Napoli N, Lombardo C, et al. Duodenal graft complications requiring duodenectomy after pancreas and pancreas-kidney transplantation[J]. Am J Transplant, 2018, 18(6): 1388-1396.
113
Hummel R, Langer M, Wolters HH, et al. Exocrine drainage into the duodenum: a novel technique for pancreas transplantation[J]. Transpl Int, 2008, 21(2): 178-181.
114
方佳丽,郭予和,马俊杰,等. 同侧胰肾联合移植146例临床效果分析[J]. 中华医学杂志2020, 100(48): 3853-3858.
115
van Dellen D, Summers A, Trevelyan S, et al. Incidence and histologic features of transplant graft pancreatitis: a single center experience[J]. Exp Clin Transplant, 2015, 13(5): 449-452.
116
Finger EB, Radosevich DM, Dunn TB, et al. A composite risk model for predicting technical failure in pancreas transplantation[J]. Am J Transplant, 2013, 13(7): 1840-1849.
117
Schneeberger S, Biebl M, Steurer W, et al. A prospective randomized multicenter trial comparing histidine-tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation[J]. Transplant Int, 2009, 22(2): 217-224.
118
Hesse UJ, Meester D, Troisi R, et al. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial[J]. Clin Transplant, 2005, 19(3): 299-303.
119
Ferrer-Fàbrega J, Cano-Vargas B, Ventura-Aguiar P, et al. Early intestinal complications following pancreas transplantation: lessons learned from over 300 cases-a retrospective single-center study[J]. Transpl Int, 2021, 34(1): 139-152.
120
Van Mellaert A, Gillard P, Jochmans I, et al. Delayed bleeding of the transplant duodenum after simultaneous kidney-pancreas transplantation: case series[J]. Transplantation, 2020, 104(1): 184-189.
121
Choi JY, Jung JH, Kwon HW,et al. Does enteric conversion affect graft survival after pancreas transplantation with bladder drainage?[J]. Ann Transplant, 2018, 23: 89-97.
122
Moya-Herraiz A, Muñoz-Bellvis L, Ferrer-Fábrega J, et al. Cooperative study of the Spanish Pancreas Transplant Group (GETP): surgical complications[J]. CirEsp, 2015, 93(5): 300-306.
123
Sharda B, Jay CL, Gurung K, et al. Improved surgical outcomes following simultaneous pancreas-kidney transplantation in the contemporary era[J]. Clin Transplant, 2022, 36(11): e14792
124
Spetzler VN, Goldaracena N, Marquez MA, et al. Duodenal leaks after pancreas transplantation with enteric drainage-characteristics and risk factors[J]. Transpl Int, 2015, 28(6): 720-728.
125
Lall CG, Sandrasegaran K, Maglinte DT, et al. Bowel complications seen on CT after pancreas transplantation with enteric drainage[J]. AJRAm J Roentgenol, 2006, 187(5): 1288-1295.
126
Bassetti M, Eckmann C, Giacobbe DR, et al. Post-operative abdominal infections: epidemiology, operational definitions, and outcomes[J]. Intensive Care Med, 2020, 46(2): 163-172.
127
Haidar G, Green M, American Society of Transplantation Infectious Diseases Community of Practice. Intra-abdominal infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13595.
128
Ziaja J, Krol R, Chudek J, et al. Intra-abdominal infections after simultaneous pancreas- kidney transplantation[J]. Ann Transplant, 2011, 16(3): 36-43.
129
Steurer W, Bonatti H, Obrist P, et al. Incidence of intraabdominal infection in a consecutive series of 40 enteric-drained pancreas transplants with FK506 and MMF immunosuppression[J]. Transpl Int, 2000, 13(Suppl 1): S195-S198.
130
Flateau C, Aït-Ammar N, Angebault C, et al. Risk factors for intra‐abdominal fungal infection after simultaneous pancreas‐kidney transplantation: a single-center retrospective experience[J]. Transpl Infect Dis, 2021, 23(2): e13486.
131
Lim S. Metabolic acidosis[J]. Acta Med Indones, 2007, 39(3): 145-150.
132
Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment[J]. Am J Kidney Dis, 2005, 45(6): 978-993.
133
Ritter A, Mohebbi N. Causes and consequences of metabolic acidosis in patients after kidney transplantation[J]. Kidney Blood Press Res, 2020, 45(6): 792-801.
134
Rossi AP, Bone BA, Edwards AR, et al. Graft-versus-host disease after simultaneous pancreas-kidney transplantation: a case report and review of the literature[J]. Am J Transplant, 2014, 14(11): 2651-2656.
135
Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium[J]. Biol Blood Marrow Transplant, 2016, 22(1): 4-10.
136
Singh P, Razonable RR, Lorenz EC, et al. Chronic graft-versus-host disease in pancreas after kidney transplant recipients-an unrecognized entity[J]. Am J Transplant, 2021, 21(2): 883-888.
137
Guy S, Potluri A, Xiao G, et al. Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report[J]. Transplant Proc, 2014, 46(7): 2446-2449.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[9] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[10] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?